光辉霉素治疗恶性疾病引起的高钙血症。
Mithramycin for hypercalcemia of malignant disease.
作者信息
Godfrey T E
出版信息
Calif Med. 1971 Oct;115(4):1-4.
Abstract
Mithramycin (Mithracin(R)) rapidly controlled the hypercalcemia of malignant disease in every patient. This control was temporary, and intermittent administration of the antibiotic was required.Hypercalcemia frequently responds to non-toxic maneuvers such as hydration and moderate doses of corticoids. Until the mechanism of action of Mithramycin in hypercalcemia is better understood, caution should be urged in its prolonged use for this purpose.
摘要
光辉霉素（普卡霉素）能迅速控制每位恶性疾病患者的高钙血症。这种控制是暂时的，需要间歇性使用抗生素。高钙血症通常对诸如补液和中等剂量皮质类固醇等无毒措施有反应。在光辉霉素治疗高钙血症的作用机制得到更好理解之前，应谨慎长期使用该药用于此目的。
相似文献
1
Mithramycin for hypercalcemia of malignant disease.光辉霉素治疗恶性疾病引起的高钙血症。
Calif Med. 1971 Oct;115(4):1-4.
2
Symptomatic hypocalcemia following combined calcitonin and mithramycin therapy for hypercalcemia due to malignancy.
Cancer Treat Rep. 1978 Oct;62(10):1561-3.
3
Hypercalcemic crisis in neoplastic diseases: management with mithramycin.
Surgery. 1972 Apr;71(4):631-5.
4
[Cancer-induced hypercalcemia. Effective treatment with mithramycin].[癌症诱发的高钙血症。光辉霉素治疗有效]
Tidsskr Nor Laegeforen. 1981 Apr 20;101(11):634-6.
5
[Treatment of hypercalcemia with mithramycin].
Rev Rhum Mal Osteoartic. 1975 Feb;42(2):93-6.
6
Acute hypercalcemia--a review and case report illustrating therapeutic value of mithramycin.急性高钙血症——一篇综述及病例报告，阐述光辉霉素的治疗价值
J Okla State Med Assoc. 1977 Jul;70(7):255-61.
7
Malignant hypercalcemia: treatment with thyrocalcitonin and mithramycin.
J Kans Med Soc. 1977 Feb;78(2):63-4, 78.
8
[Parathyroid crisis. Fatal course despite control of hypercalcemia with mithramycin].[甲状旁腺危象。尽管用光辉霉素控制了高钙血症，但仍呈致命病程]
Schweiz Med Wochenschr. 1988 Jun 4;118(22):862-5.
9
[Letter: Treatment of hypercalcemia. Value of mithramycin].[信件：高钙血症的治疗。光辉霉素的价值]
Nouv Presse Med. 1975 Apr 26;4(17):1290.
10
[Mithramycin therapy of hypercalcemia in patients with neoplastic diseases].
Ugeskr Laeger. 1974 Aug 5;136(32):1814-7.
引用本文的文献
1
Relative importance of renal failure and increased bone resorption in the hypercalcaemia of myelomatosis.肾衰竭和骨吸收增加在骨髓瘤高钙血症中的相对重要性。
J Clin Pathol. 1981 Jan;34(1):54-7. doi: 10.1136/jcp.34.1.54.
2
Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. II. Assay methods, adriamycin and the other antitumour antibiotics.抗肿瘤药物溶液在体外试验制备和储存过程中的稳定性。II. 检测方法、阿霉素及其他抗肿瘤抗生素
Cancer Chemother Pharmacol. 1986;17(1):1-10. doi: 10.1007/BF00299858.
3
The pathophysiology and clinical aspects of hypercalcemic disorders.高钙血症疾病的病理生理学与临床方面
West J Med. 1978 Oct;129(4):278-320.
本文引用的文献
1
Hypercalcemia in neoplastic disease.
Cancer. 1956 Nov-Dec;9(6):1135-40. doi: 10.1002/1097-0142(195611/12)9:6<1135::aid-cncr2820090611>3.0.co;2-6.
2
Hypercalcemia of malignant disease.恶性肿瘤引起的高钙血症
Calif Med. 1967 Jul;107(1):54-61.
3
Effect of mithramycin on calcium and hydroxyproline metabolism in patients with malignant disease.光辉霉素对恶性疾病患者钙和羟脯氨酸代谢的影响。
Br Med J. 1967 Feb 25;1(5538):474-7. doi: 10.1136/bmj.1.5538.474.
4
Mithramycin treatment of malignant hypercalcaemia.光辉霉素治疗恶性高钙血症。
Br Med J. 1968 Jul 20;3(5611):167-8. doi: 10.1136/bmj.3.5611.167.
5
Mithramycin treatment of hypercalcemia.光辉霉素治疗高钙血症。
Cancer. 1970 Feb;25(2):389-94. doi: 10.1002/1097-0142(197002)25:2<389::aid-cncr2820250217>3.0.co;2-x.
Zotero 插件